Cargando…

Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome

We report the first case of a 12‐year‐old boy with Wiskott‐Aldrich syndrome who developed CD20‐weakly expressed and CD30‐highly expressed Epstein‐Barr virus–related post‐transplant lymphoproliferative disorder refractory to rituximab treatment. The patient was effectively and safely treated with per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Bixin, Zhou, Chen, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142797/ https://www.ncbi.nlm.nih.gov/pubmed/34084507 http://dx.doi.org/10.1002/ccr3.4111

Ejemplares similares

Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
por: Agarwal, Nikki, et al.
Publicado: (2021)

Síndrome de Wiskott - Aldrich /
por: Tello Gabriel, Adriana

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
por: Feuillet, S., et al.
Publicado: (2009)

Unraveling the Repertoire in Wiskott–Aldrich Syndrome
por: Petersen, Sven H., et al.
Publicado: (2014)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
por: Liu, Li, et al.
Publicado: (2020)

Autoimmunity in Wiskott–Aldrich Syndrome: An Unsolved Enigma
por: Catucci, Marco, et al.
Publicado: (2012)

Autoimmunity in Wiskott–Aldrich Syndrome: Updated Perspectives
por: Sudhakar, Murugan, et al.
Publicado: (2021)

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
por: Rai, Rajeev, et al.
Publicado: (2020)

Hematopoietic Stem Cell Therapy for Wiskott–Aldrich Syndrome: Improved Outcome and Quality of Life
por: Mallhi, Kanwaldeep K, et al.
Publicado: (2021)

Differential analysis of immune reconstitution after allogeneic hematopoietic stem cell transplantation in children with Wiskott-Aldrich syndrome and chronic granulomatous disease
por: Zhou, Ya, et al.
Publicado: (2023)

Rare solid tumors in a patient with Wiskott–Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature
por: Coppola, Emma, et al.
Publicado: (2023)

Child with Wiskott–Aldrich syndrome underwent atypical immune reconstruction after umbilical cord blood transplantation: A case report
por: Li, Bo-Han, et al.
Publicado: (2019)

Corneal ulceration and episcleritis associated with Wiskott–Aldrich syndrome
por: Zagelbaum, Bruce M., et al.
Publicado: (2016)

Wiskott-Aldrich Syndrome: New Perspectives in Pathogenesis and Management
por: Standen, G. R.
Publicado: (1988)

Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation
por: Okamoto, Tatsuya, et al.
Publicado: (2022)

Unrelated Bone Marrow Transplantation with a Reduced Toxicity Myeloablative Conditioning Regimen in Wiskott-Aldrich Syndrome
por: Kang, Hyoung Jin, et al.
Publicado: (2008)

Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott–Aldrich Syndrome
por: Hosahalli Vasanna, Smitha, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
por: Braun, Adam, et al.
Publicado: (2023)

Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes
por: Fujimoto, Ayumi, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome
por: Shekhovtsova, Zhanna, et al.
Publicado: (2017)

Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott–Aldrich Syndrome Using Their Father as the Donor
por: Smith, Jasmine, et al.
Publicado: (2021)

A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
por: Consiglieri, Giulia, et al.
Publicado: (2021)

T cell lines characterize events in the pathogenesis of the Wiskott- Aldrich syndrome
Publicado: (1992)

The Wiskott-Aldrich Syndrome: The Actin Cytoskeleton and Immune Cell Function
por: Blundell, Michael P., et al.
Publicado: (2010)

Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments
por: Buchbinder, David, et al.
Publicado: (2014)

Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott–Aldrich Syndrome
por: Sokolic, Robert, et al.
Publicado: (2015)

A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
por: Brigida, Immacolata, et al.
Publicado: (2016)

Wiskott-Aldrich syndrome proteins in the nucleus: aWASH with possibilities
por: Verboon, Jeffrey M, et al.
Publicado: (2015)

A Novel Mutation in a Patient with Wiskott-Aldrich Syndrome
por: Öncül, Yurday, et al.
Publicado: (2020)

Wiskott-Aldrich Syndrome Protein: Roles in Signal Transduction in T Cells
por: Ngoenkam, Jatuporn, et al.
Publicado: (2021)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
por: Ainley, Louise, et al.
Publicado: (2020)

A Novel Mutation in a Child with Atypical Wiskott-Aldrich Syndrome Complicated by Cytomegalovirus Infection
por: Kaya, Zühre, et al.
Publicado: (2019)

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
por: Inoue, Hiroaki, et al.
Publicado: (2020)

Phenotypic and Genotypic Correction of WASP Gene Mutation in Wiskott-Aldrich Syndrome by Unrelated Cord Blood Stem Cell Transplantation
por: Lee, Young-Ho, et al.
Publicado: (2009)

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
por: Magnani, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n2lqgca0d3eca5h4u5rsojt80n